HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis.

Abstract
The G(M2) activator protein is required for successful degradation of G(M2) ganglioside by the A isozyme of lysosomal beta-N-acetylhexosaminidase (EC 3.2.1.52). Deficiency of the G(M2) activator protein leads to a relentlessly progressive accumulation of G(M2) ganglioside in neuronal lysosomes and subsequent fatal deterioration of central nervous system function. G(M2) activator deficiency has been described in humans, dogs and mice. This manuscript reports the discovery and characterization of a feline model of G(M2) activator deficiency that exhibits many disease traits typical of the disorder in other species. Cats deficient in the G(M2) activator protein develop clinical signs at approximately 14 months of age, including motor incoordination and exaggerated startle response to sharp sounds. Affected cats exhibit central nervous system abnormalities such as swollen neurons, membranous cytoplasmic bodies, increased sialic acid content and elevated levels of G(M2) ganglioside. As is typical of G(M2) activator deficiency, hexosaminidase A activity in tissue homogenates appears normal when assayed with a commonly used synthetic substrate. When the G(M2) activator cDNA was sequenced from normal and affected cats, a deletion of 4 base pairs was identified as the causative mutation, resulting in alteration of 21 amino acids at the C terminus of the G(M2) activator protein.
AuthorsDouglas R Martin, Nancy R Cox, Nancy E Morrison, David M Kennamer, Stephanie L Peck, Arlene N Dodson, Atoska S Gentry, Brenda Griffin, Mark D Rolsma, Henry J Baker
JournalActa neuropathologica (Acta Neuropathol) Vol. 110 Issue 5 Pg. 443-50 (Nov 2005) ISSN: 0001-6322 [Print] Germany
PMID16200419 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Complementary
  • G(M2) Activator Protein
  • G(M2) Ganglioside
  • Hexosaminidases
  • N-Acetylneuraminic Acid
Topics
  • Aging
  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Brain Chemistry
  • Cats
  • Central Nervous System (pathology, physiopathology)
  • DNA, Complementary (analysis, genetics)
  • Disease Models, Animal
  • Female
  • G(M2) Activator Protein (chemistry, deficiency, genetics, physiology)
  • G(M2) Ganglioside (analysis, metabolism)
  • Gangliosidoses, GM2 (genetics, metabolism)
  • Gene Deletion
  • Hexosaminidases (analysis)
  • Liver (enzymology)
  • Male
  • Molecular Sequence Data
  • Mutation (genetics)
  • N-Acetylneuraminic Acid (analysis)
  • Neurons (chemistry, pathology)
  • Pedigree
  • Thymus Gland (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: